Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Morgan Stanley lowers Walgreens price target to $45 ahead of earnings » 07:04
07/02/20
07/02
07:04
07/02/20
07:04
WBA

Walgreens Boots Alliance

$40.87 /

-1.51 (-3.56%)

Morgan Stanley analyst…

Morgan Stanley analyst Ricky Goldwasser lowered the firm's price target on Walgreens Boots Alliance to $45 from $49 and keeps an Equal Weight rating on the shares ahead of the company's upcoming earnings report next week. She predicts EPS of $1.16, which is modestly below the consensus forecast of $1.19. Goldwasser thinks commentary on the company's ability to manage costs, especially considering tightening of generic pricing, will be key to sentiment. She also will look for updated thoughts about store footprint and hopes to get a better understanding of the second phase of the company's transformation plan, Goldwasser tells investors in her earnings preview note.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$40.87 /

-1.51 (-3.56%)

WBA Walgreens Boots Alliance
$40.87 /

-1.51 (-3.56%)

06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/04/20 Mizuho
Walgreens Boots Alliance price target lowered to $48 from $53 at Mizuho
05/19/20 Cowen
Walgreens Boots Alliance price target lowered to $48 from $54 at Cowen
05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
WBA Walgreens Boots Alliance
$40.87 /

-1.51 (-3.56%)

WBA Walgreens Boots Alliance
$40.87 /

-1.51 (-3.56%)

WBA Walgreens Boots Alliance
$40.87 /

-1.51 (-3.56%)

WBA Walgreens Boots Alliance
$40.87 /

-1.51 (-3.56%)

Monday
Recommendations
Option Care Health should be bought on S-3 filing dip, says Lake Street » 09:07
06/29/20
06/29
09:07
06/29/20
09:07
OPCH

Option Care Health

$12.71 /

-0.59 (-4.44%)

, WBA

Walgreens Boots Alliance

$41.21 /

-0.82 (-1.95%)

Lake Street analyst…

Lake Street analyst Brooks O'Neil noted that Option Care Health (OPCH) filed a Form S-3 after the close on Friday that contains a mixed shelf registration for $500M and seeks to register the 144M shares held by Madison Dearborn and Walgreens (WBA). O'Neil, who contends that "no one paying attention should be surprised by this," believe this filing is net positive for investors and should some elect to sell out of fear he would be a buyer on the dip. He thinks it is likely Option Care can refinance debt at a lower rate and that it might be possible to sell new equity to repay debt, strengthen the balance sheet and reduce interest expense going forward, O'Neil added.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$41.21 /

-0.82 (-1.95%)

OPCH Option Care Health
$12.71 /

-0.59 (-4.44%)

OPCH Option Care Health
$12.71 /

-0.59 (-4.44%)

06/24/20 BofA
Option Care Health initiated with a Buy at BofA
05/26/20 Canaccord
Option Care Health management meetings lifts optimism, says Canaccord
02/19/20 Lake Street
Option Care Health price target raised to $23 from $18 at Lake Street
02/03/20 Lake Street
Lake Street views Option Care Health stock split 'very positively'
WBA Walgreens Boots Alliance
$41.21 /

-0.82 (-1.95%)

06/04/20 Mizuho
Walgreens Boots Alliance price target lowered to $48 from $53 at Mizuho
05/19/20 Cowen
Walgreens Boots Alliance price target lowered to $48 from $54 at Cowen
05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
WBA Walgreens Boots Alliance
$41.21 /

-0.82 (-1.95%)

OPCH Option Care Health
$12.71 /

-0.59 (-4.44%)

WBA Walgreens Boots Alliance
$41.21 /

-0.82 (-1.95%)

WBA Walgreens Boots Alliance
$41.21 /

-0.82 (-1.95%)

WBA Walgreens Boots Alliance
$41.21 /

-0.82 (-1.95%)

Over a week ago
Hot Stocks
Walgreens Boots Alliance to resume immunization services » 08:04
06/22/20
06/22
08:04
06/22/20
08:04
WBA

Walgreens Boots Alliance

$44.09 /

+2.08 (+4.95%)

Walgreens announced the…

Walgreens announced the company is resuming immunization services with additional safety measures in place for pharmacy team members and patients. The changes follow recently updated Centers for Disease Control and Prevention, or CDC, guidelines and come ahead of flu season, which health officials warn may coincide with a second wave of COVID-19. At the height of shelter-in-place orders across the country, Walgreens continued to provide only essential immunizations where the benefit outweighed the risk, and followed CDC guidelines to postpone all non-urgent, routine immunizations. Pharmacy areas maintain enhanced cleaning regimens, social distancing protocols and plexiglass shields at registers. All pharmacy team members are required to wear disposable facemasks at all times, including while administering immunizations, and follow proper glove and handwashing procedures that are standard for vaccination administration. As an additional safety measure, all pharmacy team members administering immunizations are receiving plastic face shields to be used during immunizations for eye protection. Patients entering a pharmacy are encouraged to wear a face covering to protect others and those who do not have one will be provided a facemask prior to receiving immunizations. At least six feet of distance is maintained between pharmacy waiting area chairs where patients may choose to complete paperwork and wait for their immunization or appointment.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$44.09 /

+2.08 (+4.95%)

WBA Walgreens Boots Alliance
$44.09 /

+2.08 (+4.95%)

06/04/20 Mizuho
Walgreens Boots Alliance price target lowered to $48 from $53 at Mizuho
05/19/20 Cowen
Walgreens Boots Alliance price target lowered to $48 from $54 at Cowen
05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
WBA Walgreens Boots Alliance
$44.09 /

+2.08 (+4.95%)

WBA Walgreens Boots Alliance
$44.09 /

+2.08 (+4.95%)

WBA Walgreens Boots Alliance
$44.09 /

+2.08 (+4.95%)

WBA Walgreens Boots Alliance
$44.09 /

+2.08 (+4.95%)

Hot Stocks
West Virginia Attorney General files lawsuits against Rite Aid, Walgreens » 13:23
06/04/20
06/04
13:23
06/04/20
13:23
RAD

Rite Aid

$13.55 /

+0.24 (+1.80%)

, WBA

Walgreens Boots Alliance

$43.66 /

+0.07 (+0.16%)

West Virginia Attorney…

West Virginia Attorney General Patrick Morrisey filed lawsuits against Rite Aid (RAD) and Walgreens (WBA) "alleging the two opioid distributors reaped billions of dollars in revenues, while their conduct caused immense harm to West Virginia and its citizens." The lawsuits allege Rite Aid and Walgreens "supplied far more opioids to their retail pharmacies than necessary to meet a legitimate market, and not even that was enough as the retail pharmacies ordered additional pills from other distributors to fulfill demand." The Attorney General contends Rite Aid and Walgreens "each knew its obligation to halt suspicious orders to its retail pharmacies, but failed to monitor for and report such activity." Reference Link

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$43.66 /

+0.07 (+0.16%)

RAD Rite Aid
$13.55 /

+0.24 (+1.80%)

RAD Rite Aid
$13.55 /

+0.24 (+1.80%)

04/17/20
Fly Intel: Top five analyst upgrades
04/17/20 Deutsche Bank
Rite Aid upgraded to Hold from Sell at Deutsche Bank
02/27/20
Fly Intel: Top five analyst upgrades
02/27/20 Guggenheim
Rite Aid upgraded to Neutral ahead of analyst day at Guggenheim
WBA Walgreens Boots Alliance
$43.66 /

+0.07 (+0.16%)

06/04/20 Mizuho
Walgreens Boots Alliance price target lowered to $48 from $53 at Mizuho
05/19/20 Cowen
Walgreens Boots Alliance price target lowered to $48 from $54 at Cowen
05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
WBA Walgreens Boots Alliance
$43.66 /

+0.07 (+0.16%)

RAD Rite Aid
$13.55 /

+0.24 (+1.80%)

WBA Walgreens Boots Alliance
$43.66 /

+0.07 (+0.16%)

WBA Walgreens Boots Alliance
$43.66 /

+0.07 (+0.16%)

RAD Rite Aid
$13.55 /

+0.24 (+1.80%)

WBA Walgreens Boots Alliance
$43.66 /

+0.07 (+0.16%)

RAD Rite Aid
$13.55 /

+0.24 (+1.80%)

Recommendations
Walgreens Boots Alliance price target lowered to $48 from $53 at Mizuho » 06:47
06/04/20
06/04
06:47
06/04/20
06:47
WBA

Walgreens Boots Alliance

$43.59 /

+0.07 (+0.16%)

Mizuho analyst Ann Hynes…

Mizuho analyst Ann Hynes lowered the firm's price target on Walgreens Boots Alliance to $48 from $53 and keeps a Neutral rating on the shares. The analyst sees limited earnings visibility. Based on weekly prescription data, mail order continues to outperform retail and as a result, earnings visibility is low for Walgreens in the intermediate term, Hynes tells investors in a research note. The analyst believes the shares will trade towards low historical averages.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$43.59 /

+0.07 (+0.16%)

WBA Walgreens Boots Alliance
$43.59 /

+0.07 (+0.16%)

05/19/20 Cowen
Walgreens Boots Alliance price target lowered to $48 from $54 at Cowen
05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
04/06/20 UBS
Walgreens Boots Alliance upgraded to Neutral from Sell at UBS
WBA Walgreens Boots Alliance
$43.59 /

+0.07 (+0.16%)

WBA Walgreens Boots Alliance
$43.59 /

+0.07 (+0.16%)

WBA Walgreens Boots Alliance
$43.59 /

+0.07 (+0.16%)

WBA Walgreens Boots Alliance
$43.59 /

+0.07 (+0.16%)

Over a month ago
Recommendations
Walgreens Boots Alliance price target lowered to $48 from $54 at Cowen » 07:41
05/19/20
05/19
07:41
05/19/20
07:41
WBA

Walgreens Boots Alliance

$40.40 /

+2.47 (+6.51%)

Cowen analyst Charles…

Cowen analyst Charles Ryhee lowered the firm's price target on Walgreens Boots Alliance to $48 from $54 and keeps a Market Perform rating on the shares. The analyst said the shares look oversold in the near-term and could see a reversal but he remains neutral on the long-term strategy.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$40.40 /

+2.47 (+6.51%)

WBA Walgreens Boots Alliance
$40.40 /

+2.47 (+6.51%)

05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
04/06/20 UBS
Walgreens Boots Alliance upgraded to Neutral from Sell at UBS
04/03/20 SunTrust
Walgreens Boots Alliance price target lowered to $42 from $58 at SunTrust
WBA Walgreens Boots Alliance
$40.40 /

+2.47 (+6.51%)

WBA Walgreens Boots Alliance
$40.40 /

+2.47 (+6.51%)

WBA Walgreens Boots Alliance
$40.40 /

+2.47 (+6.51%)

WBA Walgreens Boots Alliance
$40.40 /

+2.47 (+6.51%)

Periodicals
Walgreens reviewing global advertising account, AdWeek reports » 15:13
05/12/20
05/12
15:13
05/12/20
15:13
CVS

CVS Health

$63.71 /

-0.12 (-0.19%)

, IPG

Interpublic Group

$16.42 /

-0.28 (-1.68%)

, WPP

WPP

$36.14 /

-0.42 (-1.15%)

, WBA

Walgreens Boots Alliance

$41.21 /

-0.5 (-1.20%)

Walgreens (WBA) is…

Walgreens (WBA) is reviewing its global advertising account, AdWeek's Erik Oster reports. The global creative and media review includes all of its brands and follows the conclusion of the company's three-year contract with WPP (WPP), the author notes, adding that the latter is defending in the review process, which is being handled by MediaLink, according to sources. Discussions around the review dated back to before the impact of the coronavirus pandemic, and other major holding companies are also participating in the process, with the exception of IPG (IPG), which works with competitor CVS (CVS), according to a source familiar with the matter. Reference Link

ShowHide Related Items >><<
WPP WPP
$36.14 /

-0.42 (-1.15%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
03/12/20 Canaccord
Livongo Health weakness a buying opportunity, says Canaccord
02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

04/15/20 Citi
Interpublic Group price target lowered to $19 from $28 at Citi
03/25/20 JPMorgan
Interpublic Group price target lowered to $24 from $29 at JPMorgan
09/23/19 Wells Fargo
Interpublic Group initiated with a Market Perform at Wells Fargo
07/10/19 BofA
Interpublic Group upgraded to Neutral from Underperform at BofA/Merrill
WPP WPP
$36.14 /

-0.42 (-1.15%)

04/30/20 JPMorgan
WPP price target raised to 750 GBp from 630 GBp at JPMorgan
04/16/20 Kepler Cheuvreux
WPP upgraded to Buy from Hold at Kepler Cheuvreux
03/26/20 Kepler Cheuvreux
WPP upgraded to Buy from Hold at Kepler Cheuvreux
01/20/20 Goldman Sachs
WPP downgraded to Neutral from Buy at Goldman Sachs
WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
04/06/20 UBS
Walgreens Boots Alliance upgraded to Neutral from Sell at UBS
04/03/20 SunTrust
Walgreens Boots Alliance price target lowered to $42 from $58 at SunTrust
WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

Hot Stocks
Walgreens says most U.S. stores to resume standard operating hours today » 11:09
05/05/20
05/05
11:09
05/05/20
11:09
WBA

Walgreens Boots Alliance

$42.13 /

-0.33 (-0.78%)

Walgreens announced that,…

Walgreens announced that, beginning today, most Walgreens stores nationwide throughout the United States will resume standard operating hours. "The company continues to evaluate and adjust certain operations and offerings to meet the needs of its customers during the pandemic. Certain stores, specifically those located in tourist regions, downtown city centers, or markets with government-mandated curfews, will continue operating under the adjusted hours implemented in March. California stores will resume standard operating hours beginning May 18 due to local regulations. Customers can visit the store locator for specific Walgreens store and pharmacy hours. Ongoing cleaning and sanitizing will also continue to take place during operating hours. Walgreens continues to institute safety measures for employees and customers inside stores, including enhanced cleaning regimens, social distancing protocols, plexiglass shields, hygiene guidance, face covers, and providing wipes at the front of stores to clean shopping carts and baskets," the company noted.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$42.13 /

-0.33 (-0.78%)

05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
04/06/20 UBS
Walgreens Boots Alliance upgraded to Neutral from Sell at UBS
04/03/20 SunTrust
Walgreens Boots Alliance price target lowered to $42 from $58 at SunTrust
Recommendations
Walgreens shares likely react positively to Amerisource report, says Guggenheim » 08:59
05/05/20
05/05
08:59
05/05/20
08:59
WBA

Walgreens Boots Alliance

$42.46 /

+0.8 (+1.92%)

, ABC

AmerisourceBergen

$86.43 /

+0.06 (+0.07%)

After Reuters suggested…

After Reuters suggested that AmerisourceBergen (ABC) has approached Walgreens Boots Alliance (WBA) to explore a deal for its pharmaceutical wholesaling unit, Guggenheim analyst Glen Santangelo said he believes this will be viewed by investors as a positive for Walgreens. The potential of this transaction will be viewed as a surprise to investors and would suggest the company is serious about a broad restructuring and a possible leveraged buyout, Santangelo contends. Such a deal would make the previous talk of an LBO appear more possible as the company would be shrinking in both size and balance sheet leverage, the analyst noted. Meanwhile, he believes the potential transaction would be viewed "somewhat more cautiously, at least initially," by AmerisourceBergen shareholders given the longer-term strategic questions related to moving into the historically challenging European market. Santangelo has a Buy rating on AmerisourceBergen shares and a Neutral rating on Walgreens.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$42.46 /

+0.8 (+1.92%)

04/06/20
Fly Intel: Top five analyst upgrades
04/06/20 UBS
Walgreens Boots Alliance upgraded to Neutral from Sell at UBS
04/03/20 SunTrust
Walgreens Boots Alliance price target lowered to $42 from $58 at SunTrust
04/03/20 Deutsche Bank
Walgreens Boots Alliance upgraded to Hold from Sell at Deutsche Bank
ABC AmerisourceBergen
$86.43 /

+0.06 (+0.07%)

04/22/20 Credit Suisse
AmerisourceBergen assumed with an Outperform at Credit Suisse
04/01/20
Fly Intel: Top five analyst upgrades
04/01/20 JPMorgan
AmerisourceBergen upgraded to Overweight with $106 target at JPMorgan
04/01/20 JPMorgan
AmerisourceBergen upgraded to Overweight from Neutral at JPMorgan
Hot Stocks
Walgreens Boots Alliance is up 2% after Reuters report of interest in unit » 17:47
05/04/20
05/04
17:47
05/04/20
17:47
WBA

Walgreens Boots Alliance

$42.46 /

+0.8 (+1.92%)

, ABC

AmerisourceBergen

$86.43 /

+0.06 (+0.07%)

Walgreens Boots Alliance…

Walgreens Boots Alliance (WBA) is up 2% after Reuters report of AmerisourceBergen (ABC) interest in its drug distribution unit.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$42.46 /

+0.8 (+1.92%)

04/06/20
Fly Intel: Top five analyst upgrades
04/06/20 UBS
Walgreens Boots Alliance upgraded to Neutral from Sell at UBS
04/03/20 SunTrust
Walgreens Boots Alliance price target lowered to $42 from $58 at SunTrust
04/03/20 Deutsche Bank
Walgreens Boots Alliance upgraded to Hold from Sell at Deutsche Bank
ABC AmerisourceBergen
$86.43 /

+0.06 (+0.07%)

04/22/20 Credit Suisse
AmerisourceBergen assumed with an Outperform at Credit Suisse
04/01/20
Fly Intel: Top five analyst upgrades
04/01/20 JPMorgan
AmerisourceBergen upgraded to Overweight with $106 target at JPMorgan
04/01/20 JPMorgan
AmerisourceBergen upgraded to Overweight from Neutral at JPMorgan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.